India to Guatemala: Immunoglobulin Export Trade Route

The India to Guatemala Immunoglobulin corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $1.5M USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's immunoglobulin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $217.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with immunoglobulin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 33.1%, placing it at rank #19 among India's top immunoglobulin export destinations globally.

On the import side, key buyers of Indian immunoglobulin in Guatemala include SOLMEDICA PASEO CAYALA BOULEVARD RAFAEL, SOLMEDICA, CENTRAL MEDICAL STORES MINISTRY OF HEALTH. SOLMEDICA PASEO CAYALA BOULEVARD RAFAEL is the single largest importer with 4 shipments valued at $1.3M USD.

India's immunoglobulin exports to Guatemala are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Guatemala benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PVT LTD, SUNNY PHARMA — together account for 100% of total trade value on this route. The average shipment value of $217.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as human normal immunoglobulin for intravenous administration b.p., 5% solution 200ml immunorel 5% 200 ml and human normal immunoglobulin for intravenous administration b.p., 5% solution 100ml (immunorel 5% 100 ml), suggesting that buyers in Guatemala tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SOLMEDICA PASEO CAYALA BOULEVARD RAFAEL is the largest importer with 4 shipments worth $1.3M USD — representing 84% of all immunoglobulin imports from India on this route.